58
- Slagman MCJ, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink
HJ, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibi-
tion compared with dual blockade in lowering proteinuria and blood pressure: randomised
controlled trial. BMJ. 2011;343:d4366. - Rose BD. Diuretics. Kidney Int. 1991;39(2):336–52.
- Dal Canton A, Fuiano G, Conte G, Terribile M, Sabbatini M, Cianciaruso B, Andreucci
VE. Mechanism of increased plasma urea after diuretic therapy in uraemic patients. Clin Sci.
1985;68(3):255–61. - Fliser D, Schröter M, Neubeck M, Ritz E. Coadministration of thiazides increases the effi-
cacy of loop diuretics even in patients with advanced renal failure. Kidney Int. 1994;
46(2):482–8. - Moser M. Why are physicians not prescribing diuretics more frequently in the management
of hypertension? JAMA. 1998;279(22):1813–6. - Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun
DA. Characterization of resistant hypertension: association between resistant hypertension,
aldosterone, and persistent intravascular volume expansion. Arch Intern Med. 2008;168(11):
1159–64. - de Souza F, Muxfeldt E, Fiszman R, Salles G. Efficacy of spironolactone therapy in patients
with true resistant hypertension. Hypertension. 2010;55:147–52. - Vaclavík J, Sedlak R, Plachy M, Navrátil K, Plásek J, Jarkovsky J, et al. Addition of spirono-
lactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-
blind, placebo-controlled trial. Hypertension. 2011;57:1069–75. - Lobo MD, de Belder MA, Cleveland T, Collier D, Dasgupta I, Deanfield J, et al.; British
Hypertension Society; British Cardiovascular Society; British Cardiovascular Intervention
Society; Renal Association. Joint UK societie’ 2014 consensus statement on renal denerva-
tion for resistant hypertension. Heart. 2015;101:10–16. - Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, et al. Adjusted
drug treatment is superior to renal sympathetic denervation in patients with true treatment-
resistant hypertension. Hypertension. 2014;63(5):991–9.
S. Borrelli et al.